Changes in Hong Kong stocks | Golden Throat (06896) fell more than 5%, net profit decreased by 43.1% year-on-year in the first half of the year, earnings fell 12.2%

The Zhitong Finance App learned that Golden Throat (06896) fell by more than 5%. As of press release, it was down 5.51% to HK$2.23, with a turnover of HK$1,326 million.

According to the news, on the evening of August 31, Golden Throat announced its 2026 interim results. The first half of the year achieved revenue of 280 million yuan, a decrease of 12.2% over the previous year; the company's equity holders should account for 47.6 million yuan in profit, a decrease of 43.1% over the previous year. The company pointed out that the decline in revenue was mainly due to the continuous adjustment of the Group's product marketing strategy during the reporting period, and customer dealers reduced procurement in the first half of 2026, leading to a decline in sales during the period.

For the six months ended June 30, 2026, revenue from sales of Golden Throat Throat tablets (OTC) was approximately 247 million yuan, a year-on-year decrease of about 14.6%; revenue from sales of the Golden Throat Throat series products was about 27.6 million yuan, a decrease of 3.2% year on year; revenue from sales of other products was about 5.5 million yuan, an increase of 243.8% year on year. The increase was mainly due to increased sales of new products.